A Comparison of Symbicort® pMDI 2 x 160/4.5 μg Bid and 2 x 80/4.5 μg Bid With Formoterol Turbuhaler® 2 x 4.5 μg Bid and Placebo in Patients With COPD
A 12-Month Double-Blind, Double-Dummy, Randomized, Parallel Group, Multicenter Efficacy and Safety Study of Symbicort® pMDI 2 x 160/4.5 μg Bid and 2 x 80/4.5 μg Bid Compared to Formoterol Turbuhaler® 2 x 4.5 μg Bid and Placebo in Patients With COPD
3 other identifiers
interventional
1,600
9 countries
216
Brief Summary
The purpose of this study is to compare Symbicort in a pressurized metered-dose inhaler (pMDI) with formoterol and placebo in the long-term maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_3 chronic-obstructive-pulmonary-disease
Started Apr 2005
Typical duration for phase_3 chronic-obstructive-pulmonary-disease
216 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2005
CompletedFirst Submitted
Initial submission to the registry
September 13, 2005
CompletedFirst Posted
Study publicly available on registry
September 21, 2005
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2007
CompletedMarch 27, 2009
March 1, 2009
September 13, 2005
March 26, 2009
Conditions
Outcome Measures
Primary Outcomes (1)
Pre-dose and 1-hour post-dose FEV1 over the 12 months treatment period
Secondary Outcomes (4)
Patient-reported outcome variables regarding disease status (incl. PEF), collected via questionnaires and diaries
Health care utilization
Safety variables, including adverse events, vital signs, ECG, physical examination, hematology, and clinical chemistry.
all variables assessed over the 12 months treatment period
Interventions
Eligibility Criteria
You may qualify if:
- A clinical diagnosis of COPD with symptoms for more than 2 years.
- Smoking history of 10 or more pack years
- A history of at least one COPD exacerbation requiring a course of oral steroids and/or antibiotics within 1-12 months before first visit.
You may not qualify if:
- A history of asthma
- Patients taking oral steroids
- Any significant disease or disorder that may jeopardize the safety of the patient
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- AstraZenecalead
Study Sites (216)
Research Site
Birmingham, Alabama, United States
Research Site
Huntsville, Alabama, United States
Research Site
Jasper, Alabama, United States
Research Site
Muscle Shoals, Alabama, United States
Research Site
Mesa, Arizona, United States
Research Site
Phoenix, Arizona, United States
Research Site
Tucson, Arizona, United States
Research Site
Fort Smith, Arkansas, United States
Research Site
Carmichael, California, United States
Research Site
La Jolla, California, United States
Research Site
Lakewood, California, United States
Research Site
Los Angeles, California, United States
Research Site
Murrieta, California, United States
Research Site
Palo Alto, California, United States
Research Site
Peninsula, California, United States
Research Site
Pismo Beach, California, United States
Research Site
Rancho Mirage, California, United States
Research Site
Riverside, California, United States
Research Site
Sacramento, California, United States
Research Site
San Diego, California, United States
Research Site
Santa Ana, California, United States
Research Site
Stockton, California, United States
Research Site
Walnut Creek, California, United States
Research Site
Colorado Springs, Colorado, United States
Research Site
Hartford, Connecticut, United States
Research Site
Bay Pines, Florida, United States
Research Site
Clearwater, Florida, United States
Research Site
DeLand, Florida, United States
Research Site
Largo, Florida, United States
Research Site
Longwood, Florida, United States
Research Site
Miami, Florida, United States
Research Site
New Port Richey, Florida, United States
Research Site
Ormond Beach, Florida, United States
Research Site
Panama City, Florida, United States
Research Site
Tamarac, Florida, United States
Research Site
Tampa, Florida, United States
Research Site
Atlanta, Georgia, United States
Research Site
Blue Ridge, Georgia, United States
Research Site
Conyers, Georgia, United States
Research Site
Decatur, Georgia, United States
Research Site
Marietta, Georgia, United States
Research Site
Stockbridge, Georgia, United States
Research Site
Chicago, Illinois, United States
Research Site
Elk Grove Village, Illinois, United States
Research Site
Normal, Illinois, United States
Research Site
North Chicago, Illinois, United States
Research Site
O'Fallon, Illinois, United States
Research Site
Peoria, Illinois, United States
Research Site
Springfield, Illinois, United States
Research Site
Avon, Indiana, United States
Research Site
Evansville, Indiana, United States
Research Site
Indianapolis, Indiana, United States
Research Site
South Bend, Indiana, United States
Research Site
Council Bluffs, Iowa, United States
Research Site
Iowa City, Iowa, United States
Research Site
Waterloo, Iowa, United States
Research Site
Bowling Green, Kentucky, United States
Research Site
Lebanon, Kentucky, United States
Research Site
Louisville, Kentucky, United States
Research Site
Kenner, Louisiana, United States
Research Site
Lafayette, Louisiana, United States
Research Site
Shreveport, Louisiana, United States
Research Site
Slidell, Louisiana, United States
Research Site
Auburn, Maine, United States
Research Site
Bangor, Maine, United States
Research Site
Taunton, Massachusetts, United States
Research Site
Cadillac, Michigan, United States
Research Site
Portage, Michigan, United States
Research Site
Saginaw, Michigan, United States
Research Site
Edina, Minnesota, United States
Research Site
Minneapolis, Minnesota, United States
Research Site
Saint Charles, Missouri, United States
Research Site
St Louis, Missouri, United States
Research Site
Missoula, Montana, United States
Research Site
McCook, Nebraska, United States
Research Site
Omaha, Nebraska, United States
Research Site
Scottsbluff, Nebraska, United States
Research Site
Henderson, Nevada, United States
Research Site
Las Vegas, Nevada, United States
Research Site
Pahrump, Nevada, United States
Research Site
Berlin, New Jersey, United States
Research Site
Cherry Hill, New Jersey, United States
Research Site
Turnersville, New Jersey, United States
Research Site
Albany, New York, United States
Research Site
Cortland, New York, United States
Research Site
Elmira, New York, United States
Research Site
Ithaca, New York, United States
Research Site
New Hyde Park, New York, United States
Research Site
Rochester, New York, United States
Research Site
Tonawanda, New York, United States
Research Site
High Point, North Carolina, United States
Research Site
Winston-Salem, North Carolina, United States
Research Site
Chardon, Ohio, United States
Research Site
Cincinnati, Ohio, United States
Research Site
Cleveland, Ohio, United States
Research Site
Mogadore, Ohio, United States
Research Site
Toledo, Ohio, United States
Research Site
Youngstown, Ohio, United States
Research Site
Oklahoma City, Oklahoma, United States
Research Site
Tulsa, Oklahoma, United States
Research Site
Medford, Oregon, United States
Research Site
Portland, Oregon, United States
Research Site
Allentown, Pennsylvania, United States
Research Site
Beaver, Pennsylvania, United States
Research Site
Downingtown, Pennsylvania, United States
Research Site
Elverson, Pennsylvania, United States
Research Site
Philadelphia, Pennsylvania, United States
Research Site
Pittsburgh, Pennsylvania, United States
Research Site
Swarthmore, Pennsylvania, United States
Research Site
Upland, Pennsylvania, United States
Research Site
East Providence, Rhode Island, United States
Research Site
Providence, Rhode Island, United States
Research Site
Anderson, South Carolina, United States
Research Site
Charleston, South Carolina, United States
Research Site
Gaffney, South Carolina, United States
Research Site
Greenville, South Carolina, United States
Research Site
Greer, South Carolina, United States
Research Site
Spartanburg, South Carolina, United States
Research Site
Union, South Carolina, United States
Research Site
Knoxville, Tennessee, United States
Research Site
Corsicana, Texas, United States
Research Site
Dallas, Texas, United States
Research Site
El Paso, Texas, United States
Research Site
Fort Worth, Texas, United States
Research Site
Houston, Texas, United States
Research Site
San Antonio, Texas, United States
Research Site
Provo, Utah, United States
Research Site
Salt Lake City, Utah, United States
Research Site
Abingdon, Virginia, United States
Research Site
Richmond, Virginia, United States
Research Site
Spokane, Washington, United States
Research Site
Pleven, Bulgaria
Research Site
Plovdiv, Bulgaria
Research Site
Rousse, Bulgaria
Research Site
Sofia, Bulgaria
Research Site
Varna, Bulgaria
Research Site
Aalborg, Denmark
Research Site
Christiansfeld, Denmark
Research Site
Frederikshavn, Denmark
Research Site
Frederikssund, Denmark
Research Site
Hellerup, Denmark
Research Site
Kobenhavn K, Denmark
Research Site
København N, Denmark
Research Site
København NV, Denmark
Research Site
København S, Denmark
Research Site
Silkeborg, Denmark
Research Site
Skive, Denmark
Research Site
Svendborg, Denmark
Research Site
Viborg, Denmark
Research Site
Værløse, Denmark
Research Site
Cottbus, Brandenburg, Germany
Research Site
Düsseldorf, North Rhine-Westphalia, Germany
Research Site
Münster, North Rhine-Westphalia, Germany
Research Site
Dresden, Saxony, Germany
Research Site
Jena-Maua, Thuringia, Germany
Research Site
Bad Salzungen, Germany
Research Site
Bad Segeberg, Germany
Research Site
Berlin, Germany
Research Site
Bochum, Germany
Research Site
Bonn, Germany
Research Site
Cologne, Germany
Research Site
Erfurt, Germany
Research Site
Frankfurt, Germany
Research Site
Freiburg im Breisgau, Germany
Research Site
Geesthacht, Germany
Research Site
Gelnhausen, Germany
Research Site
Gelsenkirchen, Germany
Research Site
Grobhansdorf, Germany
Research Site
Hanover, Germany
Research Site
Kassel, Germany
Research Site
Leipzig, Germany
Research Site
Mainz, Germany
Research Site
Marburg, Germany
Research Site
München, Germany
Research Site
Neuruppin, Germany
Research Site
Potsdam, Germany
Research Site
Athens, Greece
Research Site
Hraklion- Crete, Greece
Research Site
Larissa, Greece
Research Site
Thessaloniki, Greece
Research Site
Budapest, Hungary
Research Site
Cegléd, Hungary
Research Site
Deszk, Hungary
Research Site
Érd, Hungary
Research Site
Füzesabony, Hungary
Research Site
Godolli, Hungary
Research Site
Gyöngyös, Hungary
Research Site
Győr, Hungary
Research Site
Gyula, Hungary
Research Site
Jászberény, Hungary
Research Site
Keszthely, Hungary
Research Site
Kiskunhalas, Hungary
Research Site
Mosdós, Hungary
Research Site
Mosonmagyaróvár, Hungary
Research Site
Nógrádgárdony, Hungary
Research Site
Pécs, Hungary
Research Site
Salgótarján, Hungary
Research Site
Sárvár, Hungary
Research Site
Siófok, Hungary
Research Site
Szarvas, Hungary
Research Site
Százhalombatta, Hungary
Research Site
Szeged, Hungary
Research Site
Szombathely, Hungary
Research Site
Tatabánya, Hungary
Research Site
Törökbálint, Hungary
Research Site
Veszprém, Hungary
Research Site
Zalaegerszeg, Hungary
Research Site
Zalaegerszeg-Pozva, Hungary
Research Site
Reykjavik, Iceland
Research Site
Mexico City, D.F., Mexico
Research Site
Guadalajara, Jalisco, Mexico
Research Site
Monterrey, Nuevo León, Mexico
Research Site
Brasov, Romania
Research Site
Bucharest, Romania
Research Site
Deva, Romania
Research Site
Iași, Romania
Related Publications (3)
Bafadhel M, Peterson S, De Blas MA, Calverley PM, Rennard SI, Richter K, Fageras M. Predictors of exacerbation risk and response to budesonide in patients with chronic obstructive pulmonary disease: a post-hoc analysis of three randomised trials. Lancet Respir Med. 2018 Feb;6(2):117-126. doi: 10.1016/S2213-2600(18)30006-7. Epub 2018 Jan 10.
PMID: 29331313DERIVEDMake BJ, Eriksson G, Calverley PM, Jenkins CR, Postma DS, Peterson S, Ostlund O, Anzueto A. A score to predict short-term risk of COPD exacerbations (SCOPEX). Int J Chron Obstruct Pulmon Dis. 2015 Jan 27;10:201-9. doi: 10.2147/COPD.S69589. eCollection 2015.
PMID: 25670896DERIVEDBleecker ER, Meyers DA, Bailey WC, Sims AM, Bujac SR, Goldman M, Martin UJ. ADRB2 polymorphisms and budesonide/formoterol responses in COPD. Chest. 2012 Aug;142(2):320-328. doi: 10.1378/chest.11-1655.
PMID: 22383665DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
AstraZeneca Symbicort Medical Science Director, MD
AstraZeneca
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
September 13, 2005
First Posted
September 21, 2005
Study Start
April 1, 2005
Study Completion
September 1, 2007
Last Updated
March 27, 2009
Record last verified: 2009-03